Brookfield Corp’s Fresenius Medical Care FMS Stock Holding History

Brookfield Corp’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,205	Closed	-$259K	–	648
2023 Q1	$259K	Buy	+12,205	New	+$234K	﹤0.01%	634

Other funds holding FMS

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brookfield Corp's FMS Position: Q2 2023 in Review

Brookfield Corp sold out of Fresenius Medical Care (FMS) in Q2 2023, closing a stake of 12,205 shares — an estimated $259K sold.

Brookfield Corp first reported a position in FMS in Q1 2023 and held it in 1 quarter. The position peaked at $259K in Q1 2023. 144 funds tracked by Wall St. Rank hold FMS as of Q2 2023.

Brookfield Corp reported no remaining Fresenius Medical Care position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 12,205 Fresenius Medical Care shares in Q2 2023, an estimated $259K.
Brookfield Corp first reported a position in Fresenius Medical Care in Q1 2023 and held it in 1 quarter.
Brookfield Corp's Fresenius Medical Care position peaked at $259K in Q1 2023.
144 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.